252 related articles for article (PubMed ID: 18611440)
1. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.
Park TS; Rosebury W; Kindt EK; Kowala MC; Panek RL
Pharmacol Res; 2008 Jul; 58(1):45-51. PubMed ID: 18611440
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
[TBL] [Abstract][Full Text] [Related]
3. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration.
Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye KA; Stocker R; Jessup W; Garner B
Biochem Pharmacol; 2007 May; 73(9):1340-6. PubMed ID: 17239824
[TBL] [Abstract][Full Text] [Related]
5. Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice.
Park TS; Panek RL; Rekhter MD; Mueller SB; Rosebury WS; Robertson A; Hanselman JC; Kindt E; Homan R; Karathanasis SK
Atherosclerosis; 2006 Dec; 189(2):264-72. PubMed ID: 16458317
[TBL] [Abstract][Full Text] [Related]
6. Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol.
Li Z; Park TS; Li Y; Pan X; Iqbal J; Lu D; Tang W; Yu L; Goldberg IJ; Hussain MM; Jiang XC
Biochim Biophys Acta; 2009 Apr; 1791(4):297-306. PubMed ID: 19416652
[TBL] [Abstract][Full Text] [Related]
7. Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice.
Glaros EN; Kim WS; Quinn CM; Jessup W; Rye KA; Garner B
J Lipid Res; 2008 Feb; 49(2):324-31. PubMed ID: 17978313
[TBL] [Abstract][Full Text] [Related]
8. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice.
Lee BJ; Kim JS; Kim BK; Jung SJ; Joo MK; Hong SG; Kim JS; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT; Yoo HS; Oh S
J Gastroenterol Hepatol; 2010 Jun; 25(6):1105-10. PubMed ID: 20594226
[TBL] [Abstract][Full Text] [Related]
9. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids and atherosclerosis: a mechanistic connection? A therapeutic opportunity?
Tabas I
Circulation; 2004 Nov; 110(22):3400-1. PubMed ID: 15569847
[No Abstract] [Full Text] [Related]
11. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
12. Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis.
Lee YS; Choi KM; Lee S; Sin DM; Lim Y; Lee YM; Hong JT; Yun YP; Yoo HS
Cancer Biol Ther; 2012 Jan; 13(2):92-100. PubMed ID: 22336910
[TBL] [Abstract][Full Text] [Related]
13. Myriocin and d-PDMP ameliorate atherosclerosis in ApoE-/- mice via reducing lipid uptake and vascular inflammation.
Yu Z; Peng Q; Li S; Hao H; Deng J; Meng L; Shen Z; Yu W; Nan D; Bai Y; Huang Y
Clin Sci (Lond); 2020 Mar; 134(5):439-458. PubMed ID: 32091078
[TBL] [Abstract][Full Text] [Related]
14. [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice].
Fernández-Laso V; Sastre C; Egido J; Martín-Ventura JL; Blanco-Colio LM
Clin Investig Arterioscler; 2015; 27(1):17-25. PubMed ID: 25027757
[TBL] [Abstract][Full Text] [Related]
15. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
16. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
He Q; Riley RT; Sharma RP
Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
18. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
Harrington SC; Simari RD; Conover CA
Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
[TBL] [Abstract][Full Text] [Related]
19. Anti-atherosclerotic effect of cilostazol in apolipoprotein-E knockout mice.
Takase H; Hashimoto A; Okutsu R; Hirose Y; Ito H; Imaizumi T; Miyakoda G; Mori T
Arzneimittelforschung; 2007; 57(4):185-91. PubMed ID: 17515288
[TBL] [Abstract][Full Text] [Related]
20. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
